SHINE allowed more flexibility in procuring production components

May 18, 2021, 9:29AMNuclear News
SHINE executives, construction managers, and partners commemorate a construction milestone of the medical isotope production facility in March. (Photo: SHINE)

The Nuclear Regulatory Commission has approved a request by SHINE Medical Technologies for an exemption from regulations on how commercial grade equipment is defined, allowing the company to more easily procure components for the medical isotope production facility it is building in Janesville, Wis.

To continue reading, log in or create a free account!

Related Articles

DOE, NRC prepare for government shutdown

October 1, 2025, 12:03PMNuclear News

The Department of Energy and the Nuclear Regulatory Commission will furlough thousands of employees and operate at reduced capacity under a government shutdown that started after midnight on...

Valar Atomics breaks ground in Utah

September 25, 2025, 9:30AMNuclear News

El Segundo, Calif.–based reactor start-up Valar Atomics recently announced that it has broken ground on its test reactor, the Ward 250, at Utah San Rafael Energy Lab (USREL), becoming the...